NCT04305782

Brief Summary

The goal of the research is to create and evaluate a new technology for management of daily residual limb fluid volume fluctuation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 9, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 12, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

April 29, 2024

Status Verified

April 1, 2024

Enrollment Period

5 years

First QC Date

March 9, 2020

Last Update Submit

April 25, 2024

Conditions

Keywords

Prosthetic SocketAmputeePin Lock Prosthetic Socket

Outcome Measures

Primary Outcomes (4)

  • Change in Limb Volume

    Limb volume fluctuations will be measured in real-time as socket release/relock strategies are tested. This will be accomplished using a portable bioimpedance device with thin sticky electrodes that are placed on the residual limb. Specifically, the change in limb volume will be assessed from a baseline period where no socket adjustments are made to another period within the same test session where socket adjustments are made.

    Change from baseline period (no release/relock) to test period (release/relock), commonly each 1 hour long and separated by a seated period of approximately 30 minutes

  • Prosthesis Evaluation Questionnaire (PEQ)

    Participants will be asked to fill out a questionnaire related to their experience using the test socket out of lab in various test configurations. Each question on the PEQ can receive a score form 0 to 100, with higher scores indicating greater satisfaction.

    Administered following out of lab testing, after at least 2 days using the test socket in out-of-lab environments.

  • PROMIS-Fatigue

    Participants will be asked to fill out a questionnaire related to their experience using the test socket out of lab in various test configurations. Each PROMIS-Fatigue question asks participants to rank on a scale from 1 to 5 (categorical options), with higher scores indicating greater level of fatigue.

    Administered following out of lab testing, after at least 2 days using the test socket in out-of-lab environments.

  • Socket Comfort Score (SCS)

    Participants will be asked to rank their comfort while using the test socket out of lab in various test configurations. The SCS ranges from 0 to 10 (categorical), with higher scores indicating greater level of comfort.

    Administered following out of lab testing, after at least 2 days using the test socket in out-of-lab environments.

Study Arms (3)

Release/Relock Socket - In Lab

EXPERIMENTAL

The test socket will be operated by the participant in lab, following a structured protocol. This arm focuses on the order effects on the re-lock panel and pin mechanisms on limb volume.

Device: Release/Relock Socket - In Lab

Release/Relock Socket - Out of Lab

EXPERIMENTAL

The test socket will be operated by the participant out of lab, with no structured protocol. This arm focuses on the effects of the re-lock panel and pin mechanisms on participant comfort.

Device: Release/Relock Socket - Out of Lab

Release/Relock Socket & Control

EXPERIMENTAL

The test socket will be operated by the participant out of lab, with no structured protocol. This arm focuses on the comparing participant experience using the novel mechanism versus traditional socket mechanisms.

Device: Release/Relock Socket - In LabDevice: Release/Relock Socket & Control

Interventions

The participants will operate the test socket in one of two test conditions: (1) pin re-lock before panel re-lock and (2) panel re-lock before pin re-lock. Participants will test each of the two conditions in a random order, in lab, following a structured protocol. Tests will determine if the order of the re-lock mechanisms influences changes in limb volume.

Release/Relock Socket & ControlRelease/Relock Socket - In Lab

The participants will operate the test socket in one of two test conditions: (1) pin re-lock before panel re-lock and (2) panel re-lock before pin re-lock. Participants will test each of the two conditions in a random order, out of lab, with no structured protocol. Tests will determine if the order of the re-lock mechanisms changes participant experience.

Release/Relock Socket - Out of Lab

The participants will operate the test socket in one of two test conditions: (1) release/relock mechanisms enabled and (2) release/relock mechanisms disabled. Participants will test each of the two conditions in a random order, out of lab, with no structured protocol. Tests will determine how the novel release/relock mechanisms compare against traditional socket release methods.

Release/Relock Socket & Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Had trans-tibial amputation at least 18 months prior to enrollment
  • Regularly wear a definitive prosthesis for at least 7 hours per week
  • Have a residual limb length of at least 9 cm
  • K2 or higher MFCL
  • Able to walk continuously with a prosthesis for at least 2 minutes at a time
  • Sit, stand, and negotiate a step of 5.0 cm
  • Have a spare prosthesis
  • No cognitive issues
  • Good hand dexterity and strength (not frail)
  • Capable of communication over a video Zoom conference call.

You may not qualify if:

  • Current presence of skin breakdown

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Washington Bioengineering

Seattle, Washington, 98195, United States

RECRUITING

MeSH Terms

Conditions

Wounds and Injuries

Interventions

Drainage

Intervention Hierarchy (Ancestors)

TherapeuticsSurgical Procedures, Operative

Study Officials

  • Joan E Sanders, PhD

    University of Washington

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Joan E Sanders, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Department of Bioengineering

Study Record Dates

First Submitted

March 9, 2020

First Posted

March 12, 2020

Study Start

September 1, 2020

Primary Completion

September 1, 2025

Study Completion

September 30, 2025

Last Updated

April 29, 2024

Record last verified: 2024-04

Locations